<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02773264</url>
  </required_header>
  <id_info>
    <org_study_id>idr-us-001</org_study_id>
    <nct_id>NCT02773264</nct_id>
  </id_info>
  <brief_title>Validation of Ultra Sound (US) Elastography</brief_title>
  <acronym>USE</acronym>
  <official_title>Validation of Ultra Sound (US) Elastography for the Evaluation of Soft Tissue and Organ Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, single-center, non-randomised, non-blinded trial with US Elastography&#xD;
      of Patients referred to our institution to assess soft tissue and organ lesions. All patients&#xD;
      will undergo next to the clinical indicated conventional US-examination, US Elastography&#xD;
      after informed consent. After completion of these three examinations, the participation in&#xD;
      the study is completed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators propose UltraSound Elastography as an imaging method which allows for a&#xD;
      better evaluation of soft tissue and organ lesions compared to the conventional US modalities&#xD;
      used nowadays in the dayly clinical routine.&#xD;
&#xD;
      This is a prospective, single-center, non-randomised, non-blinded trial with US Elastography&#xD;
      of Patients referred to our institution to assess soft tissue and organ lesions. All patients&#xD;
      will undergo next to the clinical indicated conventional US-examination, US Elastography&#xD;
      after informed consent. After completion of these three examinations, the participation in&#xD;
      the study is completed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Non-Inferiority to conventional Ultrasound (conv. US)</measure>
    <time_frame>when scheduled for conv. US, 30minutes</time_frame>
    <description>Value of US Elastography compared to conventional US</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Superiority to conventional Ultrasound (conv. US)</measure>
    <time_frame>when scheduled for conv. US, 30minutes</time_frame>
    <description>Value of US Elastography compared to conventional US</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Soft Tissue Lesions</condition>
  <arm_group>
    <arm_group_label>UltraSound Patients</arm_group_label>
    <description>All patients will undergo next to the clinical indicated conventional US-examination, US Elastography after informed consent. After completion of these three examinations, the participation in the study is completed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>Ultrasound Elastography of soft tissue and organ lesions</description>
    <arm_group_label>UltraSound Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient scheduled for clinically indicated conventional Ultrasound examination&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient scheduled for clinically indicated conventional Ultrasound examination&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Frauenfelder, PD MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Institue of Diagnostic Radiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Frauenfelder, PD MD</last_name>
    <phone>0041442551111</phone>
    <email>thomas.frauenfelder@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marga Rominger, Prof. MD</last_name>
    <phone>0041442551111</phone>
    <email>marga.rominger@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Zurich - Diagnostic Radiology</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Frauenfelder, PD MD</last_name>
      <phone>0041442551111</phone>
      <email>thomas.frauenfelder@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Marga Rominger, Prof MD</last_name>
      <phone>0041442551111</phone>
      <email>marga.rominger@usz.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas Frauenfelder, PD MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marga Rominger, Prof MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/25960814</url>
    <description>Elastography in pancreatic solid tumours diagnoses.</description>
  </link>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 2, 2015</study_first_submitted>
  <study_first_submitted_qc>May 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2016</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

